Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma

Anticancer Research

Volumn 34, Issue 6, 2014, Pages 3225-3230

  Moschini, Marco ^a   Suardi, Nazareno ^a   Pellucchi, Federico ^b   Rocchini, Lorenzo ^a   La Croce, Giovanni ^a   Capitanio, Umberto ^a   Briganti, Alberto ^a   Damiano, Rocco ^c   Montorsi, Francesco ^a   Colombo, Renzo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Bladder cancer; Cancer specific mortality; Platelets; Radical cystectomy; Thrombocytosis

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER GRADING; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CYSTECTOMY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; LYMPH NODE INVASION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT COUNSELING; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; TERTIARY CARE CENTER; THROMBOCYTE COUNT; THROMBOCYTOSIS; TREATMENT OUTCOME; TUMOR INVASION; BLADDER TUMOR; CANCER-SPECIFIC MORTALITY; MIDDLE AGED; MORTALITY; MUSCLE TUMOR; PATHOLOGY; PLATELETS; PREOPERATIVE CARE; PROGNOSIS; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA;

BLADDER CANCER; CANCER-SPECIFIC MORTALITY; PLATELETS; RADICAL CYSTECTOMY; THROMBOCYTOSIS;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PLATELET COUNT; PREOPERATIVE CARE; PROGNOSIS; SURVIVAL RATE; THROMBOCYTOSIS; URINARY BLADDER NEOPLASMS;

EID: 84906308994     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Vaidya A, Soloway MS and Hawke C: De novo muscle-invasive bladder cancer: Is there a change in trend? J Urol 165(1): 47-50, 2001.
3. Grossman HB, Natale RB, Tangen CM, Tiguert R and Civantos F: Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349: 859-866, 2003.
4. Shariat SF, Youssef RF, Gupta A, Chade DC, Karakiewicz PI, Isbarn H, Jeldres C, Sagalowsky AI, Ashfaq R and Lotan Y: Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers. J Urol 183: 1744-1750, 2010.
5. Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF and Lerner SP: p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol 22: 1014-1024, 2004.
6. Gakis G, Todenhöfer T and Stenzl A: The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer. Curr Opin Urol 21(5): 428-433, 2011.
7. Nakano T, Chahinian AP, Shinjo M, Tonomura A, Miyake M, Togawa N, Ninomiya K and Higashino K: Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br J Cancer 77: 907-912, 1998.
8. Pedersen LM and Milman N: Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9: 1826-1830, 1996.
9. Scholz HS, Petru E, Gucer F, Haas J, Tamussino K and Winter R: Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res 20: 3983-3985, 2000.
10. Shimada H, Oohira G, Okazumi S, Matsubara H, Nabeya Y, Hayashi H, Takeda A, Gunji Y and Ochiai T: Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 198: 737-741, 2004.
11. Sasaki K, Kawai K, Tsuno NH, Sunami E and Kitayama J: Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancern. World J Surg 36(1): 192-200. doi: 10.1007/s00268-011-1329-7, 2012.
12. Todenhöfer T, Renninger M, Schwentner C, Stenzl A and Gakis G: A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors. BJU Int 110(11 Pt B): E533-540, 2012.
13. Greene FL, Gospodarowicz M, Wittekend C and Philadelphia, PA: American Joint Committee on Cancer (AJCC) staging manual. ed. 7. Philadelphia, PA: Springer; 2009.
14. Pinedo HM, Verheul HM, D'Amato RJ and Folkman J: Involvement of platelets in tumour angiogenesis? Lancet 352: 1775-1777, 1998.
15. Buck I, Morceau F, Grigorakaki C, Dicato M and Diederich M: Linking anemia to inflammation and cancer: the crucial role of TNFα. Biochem Pharmacol 77: 1572-1579, 2009.
16. Morceau F, Dicato M and Diederich M: Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis. Mediators Inflamm 2009: 405016. doi: 10.1155/2009/405016.
17. Joynson CP, Sundar S and Symonds P: Anaemia is associated with poor overall survival but not with inferior local control in patients with muscle invasive bladder carcinoma treated by radical external beam radiotherapy. A retrospective study. Clin Oncol (R Coll Radiol) 18: 728-734, 2006.
18. Saito K and Kihara K: C-Reactive protein as a biomarker for urological cancers. Nat Rev Urol 8(12): 659-666, 2011.
19. Borsig L: The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther 8(8): 1247-1255, 2008.
20. Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot C V, Coward J, Deavers MT, Vasquez HG, Urbauer D, Landen CN, Hu W, Gershenson H, Matsuo K, Shahzad MM, King ER, Tekedereli I, Ozpolat B, Ahn EH, Bond VK, Wang R, Drew AF, Gushiken F, Lamkin D, Collins K, DeGeest K, Lutgendorf SK, Chiu W, Lopez-Berestein G, Afshar-Kharghan V and Sood AK: Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 366(7): 610-618, 2012.
21. Symbas NP, Townsend MF, El-Galley R, Keane TE, Graham SD and Petros JA: Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int 86: 203-207, 2000.
22. Erdemir F, Kilciler M, Bedir S, Ozgok Y, Coban H and Erten K: Clinical significance of platelet count in patients with renal cell carcinoma. Urol Int 79: 111-116, 2007.